M-Stada

M-Stada may be available in the countries listed below.

Ingredient matches for M-Stada

Morphine

Morphine hydrochloride (a derivative of Morphine) is reported as an ingredient of M-Stada in the following countries:

• Germany

Morphine sulphate pentahydrate (a derivative of Morphine) is reported as an ingredient of M-Stada in the following countries:

• Germany

International Drug Name Search

Esilgan

Esilgan may be available in the countries listed below.

Ingredient matches for Esilgan

Estazolam

Estazolam is reported as an ingredient of Esilgan in the following countries:

• Indonesia


• Italy


• Philippines

International Drug Name Search

Orapred ODT

Orapred ODT is a brand name of prednisolone, approved by the FDA in the following formulation(s):

ORAPRED ODT (prednisolone sodium phosphate - tablet, orally disintegrating; oral)

• 
  Manufacturer: SHIONOGI INC
  
  Approval date: June 1, 2006
  
  Strength(s): EQ 10MG BASE, EQ 15MG BASE, EQ 30MG BASE ^[RLD]

Has a generic version of Orapred ODT been approved?

No. There is currently no therapeutically equivalent version of Orapred ODT available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Orapred ODT. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Rapidly dissolving robust dosage form
  Patent 6,024,981
  Issued: February 15, 2000
  Inventor(s): Khankari; Rajendra K. & Hontz; John & Chastain; Sara J. & Katzner; Leo
  Assignee(s): Cima Labs Inc.
  The invention is directed to a hard tablet that can be stored, packaged and processed in bulk. Yet the tablet dissolves rapidly in the mouth of the patient with a minimum of grit. The tablet is created from an active ingredient mixed into a matrix of a non-direct compression filler and a relatively high lubricant content.
  
  Patent expiration dates:
  
  
  • April 9, 2018
    
    ✓ 
    Drug product
    ✓ 
    Sponsor has requested patent be delisted
  
  



• 
  Rapidly dissolving robust dosage form
  Patent 6,221,392
  Issued: April 24, 2001
  Inventor(s): Khankari; Rajendra K. & Hontz; John & Chastain; Sara J. & Katzner; Leo
  Assignee(s): Cima Labs Inc.
  The invention is directed to a hard tablet that can be stored, packaged and processed in bulk. Yet the tablet dissolves rapidly in the mouth of the patient with a minimum of grit. The tablet is created from an active ingredient mixed into a matrix of a nondirect compression filler and a relatively high lubricant content.
  
  Patent expiration dates:
  
  
  • April 9, 2018
    
    ✓ 
    Drug product
    ✓ 
    Sponsor has requested patent be delisted
  
  



• 
  Taste masking rapid release coating system
  Patent 6,740,341
  Issued: May 25, 2004
  Inventor(s): Kris E.; Holt & Rajendra K.; Khankari & John; Hontz
  Assignee(s): Cima Labs Inc.
  The present invention relates to a core containing a drug encased in a spacing layer and a taste masking layer which provides effective taste masking for in-mouth disintegrable dosage forms containing highly objectionable tasting drugs, as well as dosage forms containing these cores.
  
  Patent expiration dates:
  
  
  • November 24, 2019
    
    ✓ 
    Drug product
  
  

See also...

• Orapred ODT Consumer Information (Wolters Kluwer)
• Orapred ODT Consumer Information (Cerner Multum)
• Prednisolone Consumer Information (Wolters Kluwer)
• Prednisolone Acetate Suspension Consumer Information (Wolters Kluwer)
• Prednisolone Sodium Phosphate Consumer Information (Wolters Kluwer)
• Prednisolone Sodium Phosphate Liquid Consumer Information (Wolters Kluwer)
• Prednisolone Sodium Phosphate Solution Consumer Information (Wolters Kluwer)
• Prednisolone Syrup Consumer Information (Wolters Kluwer)
• Prednisolone Consumer Information (Cerner Multum)
• Prednisolone AHFS DI Monographs (ASHP)
• Prednisolone Sodium Phosphate AHFS DI Monographs (ASHP)

Tranquo

Tranquo may be available in the countries listed below.

Ingredient matches for Tranquo

Oxazepam

Oxazepam is reported as an ingredient of Tranquo in the following countries:

• Belgium


• Luxembourg

International Drug Name Search

Nifedipin

Nifedipin may be available in the countries listed below.

Ingredient matches for Nifedipin

Nifedipine

Nifedipine is reported as an ingredient of Nifedipin in the following countries:

• Croatia (Hrvatska)


• Georgia


• Romania


• Serbia

International Drug Name Search

Azinom

Azinom may be available in the countries listed below.

Ingredient matches for Azinom

Azithromycin

Azithromycin is reported as an ingredient of Azinom in the following countries:

• Georgia

International Drug Name Search

Atifan

Atifan may be available in the countries listed below.

Ingredient matches for Atifan

Terbinafine

Terbinafine is reported as an ingredient of Atifan in the following countries:

• Bosnia & Herzegowina


• Bulgaria


• Estonia


• Latvia


• Lithuania


• Slovenia

Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Atifan in the following countries:

• Poland

International Drug Name Search

Kelocyanor

Kelocyanor may be available in the countries listed below.

Ingredient matches for Kelocyanor

Edetic Acid

Edetic Acid dicobalt salt (a derivative of Edetic Acid) is reported as an ingredient of Kelocyanor in the following countries:

• Greece

International Drug Name Search